×
戻る Agenda
OS03: Expedited Approval Systems to Accelerate Patient Access to Innovative Drugs in Japan and the US
Session Chair(s)
Kanji Hirai, RPH
Director, Regulatory Policy & Intelligence, Regulatory Affair Area, Japan Dvlpmt, MSD K.K., Japan
Speaker(s)
Geet Mankad
Director, Global Regulatory Affairs , MSD K.K., Japan
Ryo Muto
Associate Director, Regulatory Affairs Oncology, Daiichi Sankyo Co., Ltd., Japan
Yoko Aoi, PHD
Coordination Director - Office of Review Management, Pharmaceuticals and Medical Devices Agency (PMDA), Japan